Surgical treatment of differentiated thyroid carcinoma: A retrospective study

Frontiers in Bioscience

Volumn 11, Issue SUPPL. 1, 2006, Pages 2206-2212

  Sperlongano, Pasquale ^a   Parmeggiani, Domenico ^a   Pisaniello, Donatella ^a   De Falco, Massimo ^a   Sordelli, Ignazio ^a   Accardo, Marina ^a   Cuccurullo, Vincenzo ^a   Mansi, Luigi ^c   Tartaro, Gian Paolo ^a   Barbarisi, Alfonso ^b   Avenia, Nicola ^c   Parmeggiani, Umberto ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b S MARIA HOSPITAL   (Italy)

^c NONE

Author keywords

Cancer; Differentiated Thyroid Carcinoma; Neoplasia; Prognostic Factors In Thyroid Carcinoma; Total Thyroidectomy; Treatment; Tumor

Indexed keywords

EID: 33744729325     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1963     Document Type: Article

References (39)

1. Asakawa H, T. Kobayshi, Y. Konoike, Y. Tanaki, Y. Matsuzawa & M. Monden: Prognostic factors in patients with recurrent differentiated thyroid carcinoma. J Surg Oncol 64(3), 202-206 (1997)
2. Mazzaferri E.L: Radiodiodine and other treatment and outcomes. Prognostic features. In: The Thyroid, Eds: Braverman L.E., Utiger R.D., Werner and Ingbar's The Thyroid IV edition, Lippincott Co., Philadelphia 1139-1143 (1991)
3. Patey M., D. Menzies, S. Theobald, M.J. Delise, J.B. Flament & M. Plecot: Anatomo-clinical prognostic factors of papillary carcinoma of thyroid. Multivariate analysis: report of 52 cases. Ann Pathol 18(1), 10-15 (1998)
4. Thomush O, A. Machens, C. Sekulla, J. Ukkat, H. Lippert, I. Gastinger & H. Dralle: Multivariate analysis of risk factors for postoperative complications in benign goiter surgery: prospective multicenter study in Germany. World J Surg Nov. 24(11), 1335-1341 (2000)
5. Agrawal S: Diagnostic accuracy and role of fine needle aspiration cytology in management of thyroid nodules. J Surg Oncol 58, 168-172 (1995)
6. Bogazzi F, E. Martino & A. Pinchera: Role of conventional ultrasonography and color flow doppler sonography in predicting malignancy in "cold" thyroid nodules. Eur J Endocrinol 138, 141 (1998)
7. Alonso O, F. Mut, G. Lago, A. Aznarez, M. Numez, J. Canepa & G. Tonya: Tc 99 m-MIBI scanning of the thyroid gland in patients markedly decreased pertechnetate uptake. Nucl Med Commun 19(3), 257-261 (1998)
8. Mazzaferri EL: Radioiodine and other treatment and outcomes. Prognostic features. In: The Thyroid, Eds: Braverman L.E., Utiger R.D., Werner and Ingbar's The Thyroid IV edition, Lippincott Co., Philadelphia, 1159-1161 (1991)
9. Donohue J.H., S.D. Goldfien, T.R. Miller, J.S. Abele & O.H. Clark: Do the prognosis of papillary and follicular thyroid carcinomas differ entiated. Amer J Surg 148, 168 (1984)
10. Mazzaferri EL & R.L. Young: Papillary thyroid carcinoma. A 10 year follow up report of the impact of therapy in 576 patients. Amer J Med 70, 511 (1981)
11. Ruegemer JJ, I.D. Hay, E.J. Bergstralh, J.J. Ryan, K.P. Offord & C.A. Gormon: Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab, 67, 501 (1988)
12. Rao RS, H.K. Parikh, V.H. Deshmane, D.M. Parikh, S.S. Shrikhande & R. Havaldar: Prognostic factors in follicular carcinoma of thyroid: a study of 198 cases. Head Neck Mar-Apr, 18(2), 118-124 (1996)
13. Zidan J, S. Kassem & A. Kuten: Follicular carcinoma of thyroid gland: prognostic factors, treatment and survival. Amer J Clin Oncol Feb. 23(1), 1-5 (2000)
14. Beasley NJ, P.G. Walfish, I. Witterick & J.L. Freeman: Causes of death in patient with well differentiated thyroid carcinoma. Laringoscope Jun 111(6), 989-991 (2001)
15. Sebastian SO, J.M. Gonzalez, P.P. Paricho, J.S. Perez, D.P. Flores & A.P. Madrona: Papillary thyroid carcinoma: prognostic index for survival including the histological variety. Arch Surg Mar 135(3), 272-277 (2000)
16. Shaha A.R., J.P. Shah & T.R. Loree: Risk group stratification and prognostic factors in papillary carcinoma of thyroid. Ann Surg Oncol Nov 3(6), 534-538 (1996)
17. Carcangiu ML, G. Zampi, A. Pupi & J. Rosai: Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 55, 805-828 (1985)
18. Saadi H, P. Kleidermacher & C. Jr. Esselstyn: Conservative management of patients with intrathyroidal well differentiated follicular thyroid carcinoma. Surgery Jul, 130(1), 30-35 (2001)
19. Kebebew E & O. H. Clark: Differentiated thyroid cancer: complete rational approach. World J Surg Aug 24(8), 942-951 (2000)
20. Melliere D, D. Berrahal, E. Hindie, J.P. Becquemin & F. Lange: Differentiated thyroid cancer. 20 years results of a protocol based on simple prognostic criteria. Presse Med Sep. 20 26(27), 1276-1283 (1997)
21. Melliere D, D. Berrahal, E. Hindie, C. Jeanguillaume, J.P. Becquemin & F. Lange: Surveillance after treatment of differentiated thyroid cancer. Ann Chir Nov 125(9), 856-860 (2000)
22. Bellantone R., C.P. Lombardi, M. Boscherini, A. Ferrante, M. Raffaelli & F. Rubino: Prognostic factors in differentiated thyroid carcinoma: a multivariate anlysis of 234 consecutive patients. J Surg Oncol Aug 68(4), 237-241 (1998)
23. Sato N, M. Oyamatsu, Y. Koyama, I. Emura, Y. Tamiya & K. Hatakeyama: Do the level of nodal disease according to the TNM classification and the number of involved cervical nodes reflect prognosis in patients with differentiated carcinoma of the thyroid gland? J Surg Oncol Nov 69(3), 151-155 (1998)
24. Visset J, A. Hamy, E. Mirallie & J. Paineau: Locoregional recurrence of differentiated thyroid cancers: diagnosis-treatment. Ann Chir Jan 127(1), 35-39 (2002)
25. Tscholl-Ducommun J & C.E. Hediger: Papillary thyroid carcinoma: morphology and prognosis. Virchows Arch 19(A), 396 (1982)
26. Sugitani I, Y. Fujimoto: Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors. Endocr J Feb 46(1), 209-216 (1999)
27. Tubiana M, M. Schlumberger, P. Rougier, A. Laplauche, E. Benhamon & P. Gardet: Long term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 55, 794-804 (1985)
28. Steinmuller T, J. Klupp, N. Rayes, F. Ulrick, S. Jonas, K.J. Graf & P. Neuhaus: Prognostic factors in patient with differentiated thyroid carcinoma. Eur J Surg Jan 166(1), 29-33 (2000)
29. Tachikawa T, H. Kumazawa, R. Kyomoto, H. Yukawa, T. Yamashita & M. Nishikawa: Clinical study on prognostic factors in thyroid carcinoma. Nippon Jibiinkoka Gakkai Kaiho Feb 104(2), 157-64 (2001)
30. Onaran Y, S. Tezelman, N. Gurel, T. Terzioghe, H. Oguz, R. Taakol & Y. Kapran: The value of Dna content in predicting the prognosis of thyroid carcinoma in an endemic iodine deficiency region. Acta Chir Belg Feb 99(1), 30-35 (1999)
31. Ishiwata T, Y. Lino, H. Takei, T. Oyama & Y. Morishita: Tumor angiogenesis as an independent prognostic indicator in human papillary thyroid carcinoma. Oncol Rep Nov-Dec 5(6), 1343-1348 (1998)
32. Tallini G, G. Garcia-Rostan, A. Herrero, D. Zelterman, G. Viale, S. Bosari & M. Carcangjn: Down regulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories. Amer J Surg Pathol Jun 23(6), 678-685 (1999)
33. Lupoli G, G. Vitale, M. Caraglia, M.R. Fittipaldi, A. Abbruzzese, P. Tagliaferri & A.R. Bianco: Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet Feb 20 353(9153), 637-639 (1999)
34. Chiappetta G, P. Toti, F. Cetta, A. Giugliano, F. Pentimalli & I. Amendola: The RET\PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions. J Clin Endoc Metab Jan 87(1), 364-369 (2002)
35. Santoro M, M. Papotti, G. Chiappetta, G. Garcia-Rostan, M. Volante, C. Johnson, R.L. Camp, F. Pentimalli, C. Monaco, A. Herrero, M.L. Carcangiu, A. Fusco & G. Tallini: RET activation and clinical pathologic differentiated thyroid tumors. J Clin End Metab Jan 87(1), 370-379 (2002)
36. Basolo F, R. Giannini, A. Togniolo, R. Casalone, F. Pacini & P. Miccoli: Establishment of a non tumorigenic papillary thyroid cell line carrying the RET\PTC1 rearrangemente. Int J Cancer Feb 10 97(5), 608- 614 (2002)
37. Portella G, C. Borselli, M. Santoro, D. Gerbasio, J.F. Dumont & A. Fusco: Human papilloma virus 16 E7 oncogene does not cooperate with RET\PTC 3 oncogene in the neoplastic trasformation of thyroid cells in transgenic mice. Oncol Res 12(8), 347-354 (2000)
38. Bartolazzi A, A. Gasbarri, M. Capotti, G. Bussolati, T. Lucante & A. Khan: Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet May 26 357(9269), 1644-1650 (2001)
39. Takano T, A. Miyauchi, T. Yokozawa, F. Matsuzuka, I. Maeda & K. Kuma: Preoperative diagnosis of thyroid papillary and anaplastic carcinomas by Real-Time quantitative reverse transcription- polymerase chain reaction of oncofetal fibronectin messenger RNA. Cancer Research Set 15, 59, 4542-4545 (1999)